undamentalytics Newsletter

Salvadori Daniel Gesua Sive: insider trades

Officer at Abbott Laboratories. No open-market purchases and 24 sales not made under a pre-set plan, reported from September 29, 2015 to March 3, 2026.

What happened after Salvadori Daniel Gesua Sive’s sales?

After their sales, the shares moved +5.1% against the index over 12 months on average (a negative figure means selling was the right call); 44% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Salvadori Daniel Gesua Sive: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 24 −2.6% −0.6% 50% 12 −1.22 0.25 No reliable evidence
Sales, 12 months after the report 23 +5.1% +2.4% 44% 11 −0.19 0.85 No reliable evidence
Sales, 12 months after the trade 23 +4.8% +2.8% 44% 11 −0.19 0.85 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Abbott Laboratories ABT EVP AND GROUP PRESIDENT024September 29, 2015March 3, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 3, 2026March 2, 2026 ABT Sale $102,288 −33.0%not yetnot yet
January 31, 2025January 30, 2025 ABT Sale $3,054,574 +9.2%−30.3%−29.8%
March 4, 2024March 1, 2024 ABT Sale $114,116 −16.8%+3.1%+3.3%
March 2, 2023March 1, 2023 ABT Sale $109,260 −6.0%−11.7%−11.9%
March 2, 2022March 1, 2022 ABT Sale $183,164 +1.4%−7.9%−5.6%
December 28, 2021December 23, 2021 ABT Sale $8,190,140 −10.8%−2.2%−3.6%
December 15, 2021December 13, 2021 ABT Sale $7,897,365 −5.6%−3.9%−4.0%
March 2, 2021March 1, 2021 ABT Sale $200,695 −20.5%−13.8%−13.4%
August 31, 2020August 27, 2020 ABT Sale $4,751,701 −2.1%−8.7%−17.6%
March 3, 2020March 2, 2020 ABT Sale $77,812 +11.4%+20.9%+25.1%
June 27, 2019June 26, 2019 ABT Sale $5,964,000 −3.6%+1.6%+1.9%
June 13, 2019June 11, 2019 ABT Sale $869,200 −1.7%+2.4%+2.8%
March 4, 2019March 1, 2019 ABT Sale $129,792 −1.6%−7.6%−6.8%
October 2, 2018September 28, 2018 ABT Sale $366,952 +7.9%+12.8%+10.5%
May 21, 2018May 17, 2018 ABT Sale $183,600 +0.4%+19.8%+19.8%
March 2, 2018March 1, 2018 ABT Sale $53,368 +3.5%+27.2%+29.8%
December 14, 2017December 14, 2017 ABT Sale $1,555,289 +11.3%+31.6%+31.9%
November 16, 2017November 14, 2017 ABT Sale $3,913,635 +1.4%+23.0%+21.7%
October 25, 2017October 23, 2017 ABT Sale $5,430,055 +2.7%+17.3%+15.7%
September 28, 2017September 26, 2017 ABT Sale $3,307,257 +0.7%+23.3%+22.0%
March 2, 2017March 1, 2017 ABT Sale $93,776 +0.5%+19.9%+17.9%
September 28, 2016September 26, 2016 ABT Sale $33,994 −12.1%+12.6%+11.3%
March 2, 2016February 29, 2016 ABT Sale $34,589 −3.7%−2.4%−5.5%
September 29, 2015September 28, 2015 ABT Sale $32,314 +5.1%−8.9%−6.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Salvadori Daniel Gesua Sive traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.